{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["leukemic stem cells", "micheliolide"]], "OtherID": [], "CitationSubset": ["IM"], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [], "PMID": "27542251", "DateCompleted": {"Year": "2018", "Month": "02", "Day": "22"}, "DateRevised": {"Year": "2022", "Month": "04", "Day": "08"}, "Article": {"ArticleDate": [], "ELocationID": ["10.18632/oncotarget.11342"], "Language": ["eng"], "Journal": {"ISSN": "1949-2553", "JournalIssue": {"Volume": "7", "Issue": "40", "PubDate": {"Year": "2016", "Month": "Oct", "Day": "04"}}, "Title": "Oncotarget", "ISOAbbreviation": "Oncotarget"}, "ArticleTitle": "Antineoplastic effects and mechanisms of micheliolide in acute myelogenous leukemia stem cells.", "Pagination": {"StartPage": "65012", "EndPage": "65023", "MedlinePgn": "65012-65023"}, "Abstract": {"AbstractText": ["Leukemic stem cells (LSCs) greatly contribute to the initiation, relapse, and multidrug resistance of leukemia. Current therapies targeting the cell cycle and rapidly growing leukemic cells, including conventional chemotherapy, have little effect due to the self-renewal and differentiated malignant cells replenishment ability of LSCs despite their scarce supply in the bone marrow. Micheliolide (MCL) is a natural guaianolide sesquiterpene lactone (GSL) which was discovered in michelia compressa and michelia champaca plants, and has been shown to exert selective cytotoxic effects on CD34+CD38- LSCs. In this study, we demonstrate that DMAMCL significantly prolongs the lifespan of a mouse model of human acute myelogenous leukemia (AML). Mechanistic investigations further revealed that MCL exerted its cytotoxic effects via inhibition of NF-\u03baB expression and activity, and by generating intracellular reactive oxygen species (ROS). These results provide valuable insight into the mechanisms underlying MCL-induced cytotoxicity of LSCs, and support further preclinical investigations of MCL-related therapies for the treatment of AML."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Experimental Hematology, Institute of Hematology and Hospital of Blood Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020, P. R. China."}], "LastName": "Ji", "ForeName": "Qing", "Initials": "Q"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Experimental Hematology, Institute of Hematology and Hospital of Blood Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020, P. R. China."}, {"Identifier": [], "Affiliation": "The State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, Nankai University, Tianjin 300071, P. R. China."}], "LastName": "Ding", "ForeName": "Ya-Hui", "Initials": "YH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Experimental Hematology, Institute of Hematology and Hospital of Blood Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020, P. R. China."}], "LastName": "Sun", "ForeName": "Yue", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Experimental Hematology, Institute of Hematology and Hospital of Blood Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020, P. R. China."}], "LastName": "Zhang", "ForeName": "Yu", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Experimental Hematology, Institute of Hematology and Hospital of Blood Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020, P. R. China."}], "LastName": "Gao", "ForeName": "Hui-Er", "Initials": "HE"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Experimental Hematology, Institute of Hematology and Hospital of Blood Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020, P. R. China."}], "LastName": "Song", "ForeName": "He-Nan", "Initials": "HN"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Experimental Hematology, Institute of Hematology and Hospital of Blood Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020, P. R. China."}], "LastName": "Yang", "ForeName": "Ming", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Experimental Hematology, Institute of Hematology and Hospital of Blood Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020, P. R. China."}], "LastName": "Liu", "ForeName": "Xiao-Lei", "Initials": "XL"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Stomatology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020, P. R. China."}], "LastName": "Zhang", "ForeName": "Zi-Xiang", "Initials": "ZX"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Experimental Hematology, Institute of Hematology and Hospital of Blood Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020, P. R. China."}], "LastName": "Li", "ForeName": "Ying-Hui", "Initials": "YH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Experimental Hematology, Institute of Hematology and Hospital of Blood Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020, P. R. China."}], "LastName": "Gao", "ForeName": "Ying-Dai", "Initials": "YD"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Oncotarget", "NlmUniqueID": "101532965", "ISSNLinking": "1949-2553"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "NF-kappa B"}, {"RegistryNumber": "0", "NameOfSubstance": "Reactive Oxygen Species"}, {"RegistryNumber": "0", "NameOfSubstance": "Sesquiterpenes, Guaiane"}, {"RegistryNumber": "0", "NameOfSubstance": "micheliolide"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": [], "DescriptorName": "Apoptosis"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Self Renewal"}, {"QualifierName": [], "DescriptorName": "Disease Models, Animal"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Leukemia, Myeloid, Acute"}, {"QualifierName": ["immunology"], "DescriptorName": "Magnoliaceae"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, SCID"}, {"QualifierName": ["metabolism"], "DescriptorName": "NF-kappa B"}, {"QualifierName": ["drug effects", "physiology"], "DescriptorName": "Neoplastic Stem Cells"}, {"QualifierName": ["metabolism"], "DescriptorName": "Reactive Oxygen Species"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Sesquiterpenes, Guaiane"}, {"QualifierName": [], "DescriptorName": "Tumor Cells, Cultured"}, {"QualifierName": [], "DescriptorName": "Xenograft Model Antitumor Assays"}], "CoiStatement": "<b>CONFLICTS OF INTEREST</b>. The authors declare no competing financial interests."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Jamieson CH, Ailles LE, Dylla SJ, Muijtjens M, Jones C, Zehnder JL, Gotlib J, Li K, Manz MG, Keating A, Sawyers CL, Weissman IL. Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. The New England journal of medicine. 2004;351:657\u2013667.", "ArticleIdList": ["15306667"]}, {"Citation": "Thomas D, Majeti R. Burning Fat Fuels Leukemic Stem Cell Heterogeneity. Cell stem cell. 2016;19:1\u20132.", "ArticleIdList": ["27392217"]}, {"Citation": "Ramdass B, Chowdhary A, Koka PS. Hematological malignancies: disease pathophysiology of leukemic stem cells. Journal of stem cells. 2013;8:151\u2013187.", "ArticleIdList": ["24699024"]}, {"Citation": "Quek L, Otto GW, Garnett C, Lhermitte L, Karamitros D, Stoilova B, Lau IJ, Doondeea J, Usukhbayar B, Kennedy A, Metzner M, Goardon N, Ivey A, et al. Genetically distinct leukemic stem cells in human CD34-acute myeloid leukemia are arrested at a hemopoietic precursor-like stage. The Journal of experimental medicine. 2016", "ArticleIdList": ["PMC4986529", "27377587"]}, {"Citation": "Bjerkvig R, Tysnes BB, Aboody KS, Najbauer J, Terzis AJ. Opinion: the origin of the cancer stem cell: current controversies and new insights. Nature reviews Cancer. 2005;5:899\u2013904.", "ArticleIdList": ["16327766"]}, {"Citation": "Borah A, Raveendran S, Rochani A, Maekawa T, Kumar DS. Targeting self-renewal pathways in cancer stem cells: clinical implications for cancer therapy. Oncogenesis. 2015;4:e177.", "ArticleIdList": ["PMC4670961", "26619402"]}, {"Citation": "Crews LA, Jamieson CH. Selective elimination of leukemia stem cells: hitting a moving target. Cancer letters. 2013;338:15\u201322.", "ArticleIdList": ["22906415"]}, {"Citation": "Hu Y, Li S. Survival regulation of leukemia stem cells. Cellular and molecular life sciences. 2016;73:1039\u20131050.", "ArticleIdList": ["26686687"]}, {"Citation": "Wang Y, Krivtsov AV, Sinha AU, North TE, Goessling W, Feng Z, Zon LI, Armstrong SA. The Wnt/beta-catenin pathway is required for the development of leukemia stem cells in AML. Science. 2010;327:1650\u20131653.", "ArticleIdList": ["PMC3084586", "20339075"]}, {"Citation": "Giambra V, Jenkins CE, Lam SH, Hoofd C, Belmonte M, Wang X, Gusscott S, Gracias D, Weng AP. Leukemia stem cells in T-ALL require active Hif1alpha and Wnt signaling. Blood. 2015;125:3917\u20133927.", "ArticleIdList": ["PMC4548498", "25934477"]}, {"Citation": "Park S, Chapuis N, Tamburini J, Bardet V, Cornillet-Lefebvre P, Willems L, Green A, Mayeux P, Lacombe C, Bouscary D. Role of the PI3K/AKT and mTOR signaling pathways in acute myeloid leukemia. Haematologica. 2010;95:819\u2013828.", "ArticleIdList": ["PMC2864389", "19951971"]}, {"Citation": "Martelli AM, Evangelisti C, Chiarini F, McCubrey JA. The phosphatidylinositol 3-kinase/Akt/mTOR signaling network as a therapeutic target in acute myelogenous leukemia patients. Oncotarget. 2010;1:89\u2013103. doi: 10.18632/oncotarget.114.", "ArticleIdList": ["10.18632/oncotarget.114", "PMC2911128", "20671809"]}, {"Citation": "Martelli AM, Evangelisti C, Chiarini F, Grimaldi C, Cappellini A, Ognibene A, McCubrey JA. The emerging role of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling network in normal myelopoiesis and leukemogenesis. Biochimica et biophysica acta. 2010;1803:991\u20131002.", "ArticleIdList": ["20399811"]}, {"Citation": "Guzman ML, Neering SJ, Upchurch D, Grimes B, Howard DS, Rizzieri DA, Luger SM, Jordan CT. Nuclear factor-kappaB is constitutively activated in primitive human acute myelogenous leukemia cells. Blood. 2001;98:2301\u20132307.", "ArticleIdList": ["11588023"]}, {"Citation": "Guzman ML, Upchurch D, Grimes B, Howard DS, Rizzieri DA, Luger SM, Phillips GL, Jordan CT. Expression of tumor-suppressor genes interferon regulatory factor 1 and death-associated protein kinase in primitive acute myelogenous leukemia cells. Blood. 2001;97:2177\u20132179.", "ArticleIdList": ["11264190"]}, {"Citation": "Papiez MA, Krzysciak W, Szade K, Bukowska-Strakova K, Kozakowska M, Hajduk K, Bystrowska B, Dulak J, Jozkowicz A. Curcumin enhances the cytogenotoxic effect of etoposide in leukemia cells through induction of reactive oxygen species. Drug Des Devel Ther. 2016;10:557\u2013570.", "ArticleIdList": ["PMC4745860", "26893544"]}, {"Citation": "Testa U, Labbaye C, Castelli G, Pelosi E. Oxidative stress and hypoxia in normal and leukemic stem cells. Experimental hematology. 2016;44:540\u2013560.", "ArticleIdList": ["27179622"]}, {"Citation": "Trachootham D, Alexandre J, Huang P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov. 2009;8:579\u2013591.", "ArticleIdList": ["19478820"]}, {"Citation": "Guzman ML, Rossi RM, Karnischky L, Li X, Peterson DR, Howard DS, Jordan CT. The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells. Blood. 2005;105:4163\u20134169.", "ArticleIdList": ["PMC1895029", "15687234"]}, {"Citation": "Guzman ML, Rossi RM, Neelakantan S, Li X, Corbett CA, Hassane DC, Becker MW, Bennett JM, Sullivan E, Lachowicz JL, Vaughan A, Sweeney CJ, Matthews W, et al. An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells. Blood. 2007;110:4427\u20134435.", "ArticleIdList": ["PMC2234793", "17804695"]}, {"Citation": "Jin P, Madieh S, Augsburger LL. The solution and solid state stability and excipient compatibility of parthenolide in feverfew. AAPS PharmSciTech. 2007;8:E105.", "ArticleIdList": ["PMC2750358", "18181526"]}, {"Citation": "Zhai JD, Li D, Long J, Zhang HL, Lin JP, Qiu CJ, Zhang Q, Chen Y. Biomimetic semisynthesis of arglabin from parthenolide. J Org Chem. 2012;77:7103\u20137107.", "ArticleIdList": ["22849854"]}, {"Citation": "Viennois E, Xiao B, Ayyadurai S, Wang L, Wang PG, Zhang Q, Chen Y, Merlin D. Micheliolide, a new sesquiterpene lactone that inhibits intestinal inflammation and colitis-associated cancer. Laboratory investigation; a journal of technical methods and pathology. 2014;94:950\u2013965.", "ArticleIdList": ["25068660"]}, {"Citation": "Zhang Q, Lu Y, Ding Y, Zhai J, Ji Q, Ma W, Yang M, Fan H, Long J, Tong Z, Shi Y, Jia Y, Han B, et al. Guaianolide sesquiterpene lactones, a source to discover agents that selectively inhibit acute myelogenous leukemia stem and progenitor cells. Journal of medicinal chemistry. 2012;55:8757\u20138769.", "ArticleIdList": ["22985027"]}, {"Citation": "Xin H, Kong Y, Jiang X, Wang K, Qin X, Miao ZH, Zhu Y, Tan W. Multi-drug-resistant cells enriched from chronic myeloid leukemia cells by Doxorubicin possess tumor-initiating-cell properties. Journal of pharmacological sciences. 2013;122:299\u2013304.", "ArticleIdList": ["23903006"]}, {"Citation": "Zhou J, Chng WJ. Identification and targeting leukemia stem cells: The path to the cure for acute myeloid leukemia. World journal of stem cells. 2014;6:473\u2013484.", "ArticleIdList": ["PMC4172676", "25258669"]}, {"Citation": "Zeng H, Gu H, Chen C, Li M, Xia F, Xie L, Liu X, Zhang F, Tong X, Wang J, Yu Z, Zheng J. ChREBP promotes the differentiation of leukemia-initiating cells to inhibit leukemogenesis through the TXNIP/RUNX1 pathways. Oncotarget. 2016 doi: 10.18632/oncotarget.9520.", "ArticleIdList": ["10.18632/oncotarget.9520", "PMC5122394", "27224916"]}, {"Citation": "Zhang H, Mi JQ, Fang H, Wang Z, Wang C, Wu L, Zhang B, Minden M, Yang WT, Wang HW, Li JM, Xi XD, Chen SJ, et al. Preferential eradication of acute myelogenous leukemia stem cells by fenretinide. Proceedings of the National Academy of Sciences of the United States of America. 2013;110:5606\u20135611.", "ArticleIdList": ["PMC3619353", "23513221"]}, {"Citation": "Jin Y, Lu Z, Ding K, Li J, Du X, Chen C, Sun X, Wu Y, Zhou J, Pan J. Antineoplastic mechanisms of niclosamide in acute myelogenous leukemia stem cells: inactivation of the NF-kappaB pathway and generation of reactive oxygen species. Cancer research. 2010;70:2516\u20132527.", "ArticleIdList": ["20215516"]}, {"Citation": "Guzman ML, Swiderski CF, Howard DS, Grimes BA, Rossi RM, Szilvassy SJ, Jordan CT. Preferential induction of apoptosis for primary human leukemic stem cells. Proceedings of the National Academy of Sciences of the United States of America. 2002;99:16220\u201316225.", "ArticleIdList": ["PMC138592", "12451177"]}, {"Citation": "Turillazzi E, Neri M, Cerretani D, Cantatore S, Frati P, Moltoni L, Busardo FP, Pomara C, Riezzo I, Fineschi V. Lipid peroxidation and apoptotic response in rat brain areas induced by long-term administration of nandrolone: the mutual crosstalk between ROS, NF-kB. Journal of cellular and molecular medicine. 2016;20:601\u2013612.", "ArticleIdList": ["PMC5125979", "26828721"]}, {"Citation": "Riezzo I, Turillazzi E, Bello S, Cantatore S, Cerretani D, Di Paolo M, Fiaschi AI, Frati P, Neri M, Pedretti M, Fineschi V. Chronic nandrolone administration promotes oxidative stress, induction of pro-inflammatory cytokine and TNF-alpha mediated apoptosis in the kidneys of CD1 treated mice. Toxicology and applied pharmacology. 2014;280:97\u2013106.", "ArticleIdList": ["25065671"]}, {"Citation": "Bubici C, Papa S, Dean K, Franzoso G. Mutual cross-talk between reactive oxygen species and nuclear factor-kappa B: molecular basis and biological significance. Oncogene. 2006;25:6731\u20136748.", "ArticleIdList": ["17072325"]}, {"Citation": "Li L, Huang T, Tian C, Xiao Y, Kou S, Zhou X, Liu S, Ye X, Li X. Thedefensive effect of phellodendrine against AAPH-induced oxidative stress throughregulating the AKT/NF-kappaB pathway in zebrafish embryos. Life sciences. 2016", "ArticleIdList": ["27234894"]}], "ReferenceList": []}], "History": [{"Year": "2016", "Month": "2", "Day": "24"}, {"Year": "2016", "Month": "8", "Day": "9"}, {"Year": "2016", "Month": "8", "Day": "20", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "2", "Day": "23", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "8", "Day": "20", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "10", "Day": "4"}], "PublicationStatus": "ppublish", "ArticleIdList": ["27542251", "PMC5323134", "10.18632/oncotarget.11342", "11342"]}}], "PubmedBookArticle": []}